Streetbeat News

Order Imbalances

BAYRY

GOOG

IBM

INTC

MSFT

NVDA

AI is significantly impacting the pharmaceutical industry, from drug discovery to marketing, with Alphabet Inc's Google DeepMind developing AlphaFold 3, an AI model that predicts the structure of biological molecules. McKinsey reports AI could generate $60 billion-$110 billion annually for the industry, speeding up drug discovery and development. Collaborations like Bayer AG and Google Cloud are developing AI solutions for healthcare. Key players include Nvidia, Intel, IBM, Google, GE, Microsoft, Medtronic, Micron Technology, Amazon Web Services, and Siemens Healthineers.

Portfolio Pulse from Vandana Singh

May 10, 2024 | 6:49 pm

SYNX

Silynxcom has secured an order to supply equipment for a German Police Department in preparation for an upcoming international sports event. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 1:22 pm

LASE

LHX

Laser Photonics' stock price increased following the announcement of securing an order for its LaserTower COMPACT marking and engraving system from L3Harris Technologies.

Portfolio Pulse from Benzinga Newsdesk

April 09, 2024 | 12:02 pm

AAPL

BTCUSD

ETHUSD

TSLA

The article covers a range of topics from cryptocurrency trends, including Bitcoin's surge as its halving approaches, to US and world politics, the US economy, tech innovations, electric vehicles, and more. Key highlights include Bitcoin, Ethereum, and Dogecoin's price movements, Ripple CEO's market prediction, and various political and economic developments in the US and globally. It also touches on tech updates like Apple's new initiatives and Tesla's focus on autonomy.

Portfolio Pulse from Akanksha Bakshi

April 08, 2024 | 12:49 pm

MTEK

Maris-Tech announced receiving a new order worth $415,800 from an existing defense industry customer, indicating continued business and potential growth in its defense sector engagements.

Portfolio Pulse from Benzinga Newsdesk

April 03, 2024 | 12:12 pm

ATAI

META

MNMD

PSIL

TSLA

Beckley Psytech and atai Life Sciences announced positive results from a Phase 2a study of 5-MeO-DMT for Treatment Resistant Depression. Utah hospitals will soon offer psilocybin and MDMA therapy. Elon Musk discussed the benefits of ketamine for depression and its positive impact on investors. Meta is under investigation for potentially facilitating illegal drug sales. MindMed's CEO highlighted LSD's potential in a podcast. Various companies and ETFs are mentioned with their stock performance.

Portfolio Pulse from Lara Goldstein

March 29, 2024 | 4:43 pm

AMD

TSLA

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin are gaining momentum as analysts predict a positive outlook for the altcoin market and a potential rise in Bitcoin's value to $70K. In the US markets, stocks such as Esperion Therapeutics and Masimo are moving higher in pre-market sessions, despite a fall in investor sentiment. Political developments include potential actions by Trump regarding a bankruptcy trigger and Biden's comments on Trump's golf skills. In technology, AMD and Nvidia show divergent premarket movements, while China plans to replace AMD and Intel chips and Microsoft Windows in state computers. Tesla faces scrutiny over its production and valuation, but also sees developments with its Cybertruck and team. Boeing's labor union seeks a board voice, and Cathie Wood's Ark invests further in Tesla while selling a Bitcoin-linked stock. Other notable mentions include developments in Ukraine, Facebook, Nissan's electrification plans, and energy sector movements.

Portfolio Pulse from Akanksha Bakshi

March 25, 2024 | 12:51 pm

BTCUSD

ETHUSD

LULU

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin show mixed performance amid a decrease in weekly jobless claims. Ripple's CEO comments on SEC's actions against Ethereum and XRP. Lululemon's weak outlook impacts pre-market session alongside Nike. US political tensions rise with Marjorie Taylor Greene's statements. Taiwan's tech surge and China's investigation into PwC over Evergrande fraud affect the global economy. Apple faces an antitrust lawsuit, while Tesla's Cybertruck production ramps up. Air travel costs are expected to rise due to airlines passing on decarbonization expenses. Various companies face legal and market challenges.

Portfolio Pulse from Akanksha Bakshi

March 22, 2024 | 1:13 pm

CMPS

CYBN

MNMD

PSIL

Cybin Inc. received FDA Breakthrough Therapy designation for its psilocybin therapy for Major Depressive Disorder, alongside positive clinical data and a $150M private placement. MindMed also received the designation for its LSD-derived treatment for Generalized Anxiety Disorder, with expected proceeds of $175M from share offerings. Gilgamesh Pharmaceuticals was awarded a $14M grant for ibogaine analog research. Psyence Biomedical, Red Light Holland, and Clearmind Medicine were mentioned for their developments in psychedelics. The article also covered stock performances of several psychedelics companies.

Portfolio Pulse from Lara Goldstein

March 20, 2024 | 6:49 pm

BTCUSD

The weekend financial news roundup covered topics from Bitcoin's potential to address the U.S. national debt, Edward Snowden's critique of Janet Yellen, to the unexpected rise in inflation affecting Federal Reserve decisions. Coinbase CEO Brian Armstrong suggested Bitcoin as a solution to the national debt crisis. Edward Snowden highlighted a contradiction in Yellen's statements regarding U.S. financial capabilities. Inflation rates exceeding expectations in February 2024 are likely to influence the Federal Reserve's upcoming decisions, with persisting inflation adding pressure on Fed Chair Jerome Powell. Additionally, Dave Ramsey criticized the traditional retirement paradigm, advocating for a re-evaluation of life and financial planning.

Portfolio Pulse from Benzinga Neuro

March 17, 2024 | 10:45 am